玉屏风散联合抗组胺药治疗慢性荨麻疹有效性和安全性的Meta分析

目的 评价玉屏风散联合常规抗组胺药治疗慢性荨麻疹的有效性和安全性.方法 计算机检索CENTRAL、Pubmed、Embase、CBM、CNKI、VIP及万方等数据库,查找应用玉屏风散治疗慢性荨麻疹的随机对照试验.由两位评价者对文献进行独立检索筛选,采用Cochrane系统评价方法对纳入研究进行质量评价,运用RevMan 5.3软件进行Meta分析.结果 共纳入10项研究,964例患者.Meta分析结果显示:与单用抗组胺药比较,玉屏风散联合抗组胺药治疗组的疗效更好(OR=2.83,95％CI:1.89～4.25,P＜0.01),复发率更低(OR=0.13,95％CI:0.07～0.24,P＜0.01),不良反应发生率更低(OR=0.40,95％CI:0.19～0.83,P=0.01).结论 玉屏风散联合抗组胺药治疗慢性荨麻疹的疗效优于单用抗组胺药,能显著降低复发率,且安全性高,不良反应少.

Meta-analysis on effect and safety of Yupingfeng Powder combined with antihistamines for chronic urticaria

Objective To evaluate the effect and safetyof Yupingfeng Powdercombined with antihistamines for the treatment of patients with chronic urticaria.Methods Searched all randomized controlled trials (RCTs)of Yupingfeng Powder for treatment of chronic urticaria from the databases of CENTRAL,Pubmed,Embase,CNKI,CBM,VIP and Wanfang.Two researchers independently searched the literature and used the Cochrane system evaluation method to evaluate the quality of the study,and used RevMan 5.3 for meta-analysis.Results A total of 10 RCTs involving 964 patients were included in this study.Meta-analysis showed that compared with antihistamines alone,Yupingfeng Powder combined with antihistamines could improve the clinical effective rate (OR=2.83,95 ％ CI:1.89-4.25,P ＜ 0.01),reduce relapse rate (OR =0.13,95 ％ CI:0.07-0.24,P＜0.01) and reduce the incidence of adverse reactions (OR=0.40,95％CI:0.19-0.83,P=0.01).Conclusion Yupingfeng Powder combined with antihistamines has superior clinical effective rate,lower recurrence rate and incidence of adverse reactions.